NNNN
Anbio Biotechnology Class A Ordinary Shares
NASDAQ: NNNN · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$27.43
-1.37% today
Updated 2026-04-29
Market cap
$1.20B
P/E ratio
182.87
P/S ratio
139.23x
EPS (TTM)
$0.15
Dividend yield
—
52W range
$6 – $56
Volume
0.0M
Anbio Biotechnology Class A Ordinary Shares (NNNN) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
2 of 3
Last 3 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
—
Most recent quarter
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-7.2%
Last 1 reports
Positive reaction rate
0%
0 of 1 quarters
Largest single-day move
-7.2%
2025-12-30
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-12-30 | $0.09 | — | $32.39 | $30.07 | -7.2% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-09-30 | $0.00 | $0.09 | — | — | — |
| 2025-03-31 | $0.00 | $-0.03 | — | — | — |
| 2024-09-30 | $0.00 | $0.09 | — | — | — |
Frequently asked questions
Has Anbio Biotechnology Class A Ordinary Shares beaten earnings estimates?
Anbio Biotechnology Class A Ordinary Shares has beaten Wall Street EPS estimates in 2 of its last 3 quarterly reports.
How does NNNN stock react to earnings?
NNNN stock has moved an average of -7.2% in the trading day following earnings over its last 1 reports, with positive reactions in 0% of those quarters.